Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 255,841 | 79,381 | 86,218 | 74,386 | 91,339 |
| Receivables | 25,508 | 29,941 | 18,125 | 16,202 | 18,334 |
| Inventories | 9,292 | 9,624 | 11,818 | 12,852 | 12,496 |
| TOTAL | $295,480 | $123,841 | $118,503 | $110,396 | $126,903 |
| Non-Current Assets | |||||
| PPE Net | 2,426 | 2,519 | 2,611 | 2,704 | 2,796 |
| Investments And Advances | 18,707 | 17,660 | 0 | 0 | 0 |
| Intangibles | 26,479 | 27,605 | 28,670 | 29,734 | 30,798 |
| Other Non-Current Assets | 13,782 | 13,923 | 31,623 | 17,061 | 17,574 |
| TOTAL | $61,394 | $61,707 | $62,904 | $49,499 | $51,168 |
| Total Assets | $356,874 | $185,548 | $181,407 | $159,895 | $178,071 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 3,750 | N/A |
| Accounts payable and accrued liabilities | 92,986 | 47,125 | 45,171 | 48,576 | 66,286 |
| Other current liabilities | 268 | 136 | 137 | 2,071 | 2,402 |
| TOTAL | $103,393 | $49,744 | $54,067 | $57,521 | $73,674 |
| Non-Current Liabilities | |||||
| Long Term Debt | 36,878 | 52,417 | 47,774 | 50,026 | 56,382 |
| Other Non-Current Liabilities | -12,560 | 22,664 | 11,404 | 42,105 | 29,636 |
| TOTAL | $51,107 | $73,621 | $62,155 | $64,991 | $71,911 |
| Total Liabilities | $154,500 | $123,365 | $116,222 | $122,512 | $145,585 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 33,219 | 32,203 | 31,038 | 29,755 | 29,570 |
| Common Shares | 33 | 31 | 31 | 30 | 30 |
| Retained earnings | -623,679 | -734,052 | -730,115 | -735,965 | -751,451 |
| Other shareholders' equity | 40,166 | 12,310 | 9,323 | -6,541 | 10,236 |
| TOTAL | $202,374 | $62,183 | $65,185 | $37,383 | $32,486 |
| Total Liabilities And Equity | $356,874 | $185,548 | $181,407 | $159,895 | $178,071 |